BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gopalan N, Chandrasekaran P, Swaminathan S, Tripathy S. Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis. AIDS Res Ther 2016;13:34. [PMID: 27708678 DOI: 10.1186/s12981-016-0118-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Kosgei RJ, Callens S, Gichangi P, Temmerman M, Kihara AB, David G, Omesa EN, Masini E, Carter EJ. Gender difference in mortality among pulmonary tuberculosis HIV co-infected adults aged 15-49 years in Kenya. PLoS One 2020;15:e0243977. [PMID: 33315954 DOI: 10.1371/journal.pone.0243977] [Reference Citation Analysis]
2 Schaaf HS, Garcia-prats AJ, Mckenna L, Seddon JA. Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children. Expert Review of Clinical Pharmacology 2018;11:233-44. [DOI: 10.1080/17512433.2018.1421067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
3 Beiranvand E, Abediankenari S, Valiyari S, Rezaei MS, Rostamian M, Beiranvand B, Khaligh A, Khani S. Single nucleotide polymorphisms of IFNγ (+874 A/T) and IFNγR1 (-56 C/T) in Iranian patients with TB. Trans R Soc Trop Med Hyg 2016;110:604-9. [PMID: 27941164 DOI: 10.1093/trstmh/trw074] [Reference Citation Analysis]
4 Kebede F, Kebede T, Kebede B, Abate A, Jara D, Negese B, Shaweno T. Time to Develop and Predictors for Incidence of Tuberculosis among Children Receiving Antiretroviral Therapy. Tuberc Res Treat 2021;2021:6686019. [PMID: 34812290 DOI: 10.1155/2021/6686019] [Reference Citation Analysis]
5 Reis AJ, Diniz JLCG, Silva ABS, Silveira J, Basso R, Vieira R, von Groll A, Ramis IB, da Silva PEA. Laboratory tools for tuberculosis control in a setting with a high burden of HIV/AIDS. J Med Microbiol 2019;68:1622-8. [PMID: 31596198 DOI: 10.1099/jmm.0.001089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mehta S, Peters RP, Smit DP, Gupta V. Ocular Tuberculosis in HIV-infected Individuals. Ocul Immunol Inflamm 2020;28:1251-8. [PMID: 32809898 DOI: 10.1080/09273948.2020.1776882] [Reference Citation Analysis]
7 Wong K, Nguyen J, Blair L, Banjanin M, Grewal B, Bowman S, Boyd H, Gerstner G, Cho HJ, Panfilov D, Tam CK, Aguilar D, Venketaraman V. Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection. J Clin Med 2020;9:E3575. [PMID: 33172001 DOI: 10.3390/jcm9113575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
8 Kebede F, Kebede B, Kebede T, Agmasu M. Effect of Isoniazid Preventive Therapy on the Incidence of Tuberculosis among Seropositive Children Attending HIV/AIDS Care in Two General Hospitals, Northwest Ethiopia, 2021. J Trop Med 2021;2021:9996953. [PMID: 34545289 DOI: 10.1155/2021/9996953] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Moreno S, Perno CF, Mallon PW, Behrens G, Corbeau P, Routy JP, Darcis G. Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? HIV Med 2019;20 Suppl 4:2-12. [PMID: 30821898 DOI: 10.1111/hiv.12716] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
10 Proud Tembo NF, Bwalya Muma J, Hang'ombe B, Munyeme M. Clustering and spatial heterogeneity of bovine tuberculosis at the livestock/wildlife interface areas in Namwala District of Zambia. Vet World 2020;13:478-88. [PMID: 32367953 DOI: 10.14202/vetworld.2020.478-488] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Igarashi M, Ishizaki Y, Takahashi Y. New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development. J Antibiot (Tokyo) 2017. [PMID: 29089593 DOI: 10.1038/ja.2017.126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
12 Oliveira PR, Schibelbain AF, Neiva EG, Zarbin AJ, Marcolino- LH, Bergamini MF. Nickel hexacyanoferrate supported at nickel nanoparticles for voltammetric determination of rifampicin. Sensors and Actuators B: Chemical 2018;260:816-23. [DOI: 10.1016/j.snb.2017.12.198] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M; International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis 2019;19:298-307. [PMID: 30744962 DOI: 10.1016/S1473-3099(18)30673-X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
14 Quinn CM, Poplin V, Kasibante J, Yuquimpo K, Gakuru J, Cresswell FV, Bahr NC. Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of Disease. Life (Basel) 2020;10:E262. [PMID: 33138069 DOI: 10.3390/life10110262] [Cited by in F6Publishing: 2] [Reference Citation Analysis]